Ellis AL - Search Results

1

Time course of phorbol-12-myristate-13-acetate (PMA)-induced down-regulation of topoisomerase II in human leukemia cells.

Ellis AL, Zwelling LA. Ellis AL, et al. Biochem Pharmacol. 1994 Nov 1;48(9):1842-5. doi: 10.1016/0006-2952(94)90472-3. Biochem Pharmacol. 1994. PMID: 7980655

2

Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.

Ellis AL, Nowak B, Plunkett W, Zwelling LA. Ellis AL, et al. Cancer Chemother Pharmacol. 1994;34(3):249-56. doi: 10.1007/BF00685085. Cancer Chemother Pharmacol. 1994. PMID: 8004759

3

Phorbol regulation of topoisomerases I and II in human leukemia cells. Studies in an additional cell pair sensitive or resistant to phorbol-induced differentiation.

Ellis AL, Altschuler E, Bales E, Hinds M, Mayes J, Soares L, Zipf TF, Zwelling LA. Ellis AL, et al. Biochem Pharmacol. 1994 Jan 20;47(2):387-96. doi: 10.1016/0006-2952(94)90030-2. Biochem Pharmacol. 1994. PMID: 8304982

4

Topotecan in chronic lymphocytic leukemia.

O'Brien S, Kantarjian H, Ellis A, Zwelling L, Estey E, Keating M. O'Brien S, et al. Cancer. 1995 Mar 1;75(5):1104-8. doi: 10.1002/1097-0142(19950301)75:5<1104::aid-cncr2820750509>3.0.co;2-b. Cancer. 1995. PMID: 7850708 Clinical Trial.

5

Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia.

Kantarjian HM, Beran M, Ellis A, Zwelling L, O'Brien S, Cazenave L, Koller C, Rios MB, Plunkett W, Keating MJ, et al. Kantarjian HM, et al. Blood. 1993 Mar 1;81(5):1146-51. Blood. 1993. PMID: 8382970 Free article. Clinical Trial.

6

Components of intrinsic drug resistance in the rat hepatoma.

Ellis AL, Munger CE, Bunch RT, Woods KE, Randolph JK, Boise L, Swerdlow PS, Zwelling LA, Hinds M, Yanovich S, et al. Ellis AL, et al. Biochem Pharmacol. 1992 Jan 22;43(2):331-42. doi: 10.1016/0006-2952(92)90296-u. Biochem Pharmacol. 1992. PMID: 1310853

7

Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor.

Abbruzzese JL, Madden T, Sugarman SM, Ellis AL, Loughlin S, Hess KR, Newman RA, Zwelling LA, Raber MN. Abbruzzese JL, et al. Among authors: ellis al. Clin Cancer Res. 1996 Sep;2(9):1489-97. Clin Cancer Res. 1996. PMID: 9816325 Clinical Trial.

8

Biochemical lesions in DNA associated with the antiproliferative effects of mitoxantrone in the hepatoma cell.

Ellis AL, Randolph JK, Conway BR, Gewirtz DA. Ellis AL, et al. Biochem Pharmacol. 1990 May 15;39(10):1549-56. doi: 10.1016/0006-2952(90)90520-u. Biochem Pharmacol. 1990. PMID: 2337411

9

Expression of protein-associated DNA damage in the alkaline elution assay in the absence of enzymatic deproteinization.

Gewirtz DA, Ellis AL, Randolph JK, Yanovich S, Swerdlow PS, Povirk LF, Yalowich JC. Gewirtz DA, et al. Among authors: ellis al. Cancer Commun. 1989;1(3):175-80. Cancer Commun. 1989. PMID: 2561738

10

Applying Community-based System Dynamics to promote child health equity: the case of healthy and fit kids in Milwaukee, WI.

Greer YD, Nevels D, Meinen A, Korth AL, Moore TR, Appel J, Werner K, Calancie L, Ellis AL, Espy N, Hendricks S, Johnson T, Johnson VD, Nabak D, Rembert V, Simenz C, Weeks N, Wilks-Tate A, Economos CD. Greer YD, et al. Among authors: ellis al. Front Public Health. 2024 Nov 14;12:1375284. doi: 10.3389/fpubh.2024.1375284. eCollection 2024. Front Public Health. 2024. PMID: 39610382 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters